Meftal-Spas Injection contains Dicyclomine 10mg, an anticholinergic agent used primarily for the relief of smooth muscle spasms in the gastrointestinal tract. It exerts its therapeutic effect by blocking the action of acetylcholine on muscarinic receptors, thereby reducing muscle spasms and associated pain. This injection is indicated for the management of conditions such as irritable bowel syndrome, biliary colic, renal colic, and other spastic disorders of the gastrointestinal tract. Meftal-Spas Injection provides rapid onset of action, making it suitable for acute symptomatic relief. It is administered intramuscularly or intravenously under medical supervision, with dosage tailored according to the severity of symptoms and patient response. Common side effects may include dry mouth, dizziness, blurred vision, and tachycardia, while caution is advised in patients with glaucoma, myasthenia gravis, or obstructive gastrointestinal conditions. Contraindications include hypersensitivity to dicyclomine or related compounds. Use during pregnancy and lactation should be under strict medical guidance. Meftal-Spas Injection should be stored at controlled room temperature, protected from light and moisture. Proper medical evaluation is essential before initiating therapy to ensure safety and efficacy.